- Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Expires: February 28, 2011 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

INGERSOLL W BRETT

2. Date of Event Requiring Statement (MM/DD/YYYY) 9/30/2009

3. Issuer Name and Ticker or Trading Symbol

Talecris Biotherapeutics Holdings Corp. [TLCR]

(Last) (First) (Middle)

C/O TALECRIS BIOTHERAPEUTICS HOLDINGS, P.O. BOX 110526 4101 RESEARCH COMMONS

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)

(Street)

RESEARCH TRIANGLE PARK, NC 27709

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.01 per share	0 ⁽¹⁾ ⁽²⁾	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:
( 1)	This Form 3 is being filed as a result of the registration, as of September 30, 2009, of the common stock, par value $0.01 per share (the "Common Stock"), of Talecris Biotherapeutics Holdings Corp., a Delaware corporation (the "Company"), pursuant to the Securities Exchange Act of 1934, as amended, as part of the Company's initial public offering effected on such date. The reporting person is a director of the Company.
( 2)	The reporting person does not individually hold or otherwise beneficially own any securities of the Company. The reporting person is an employee of Cerberus Capital Management, L.P., one or more affiliates of which own certain securities of the Company, all of which are subject to the sole voting and investment discretion of Stephen Feinberg. Mr. Feinberg, in his capacity as the holder of sole voting and investment authority of more than 10% of the outstanding shares of Common Stock pursuant to Reg. 13d-3, separately files statements pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934, as amended. The reporting person does not exercise any voting, investment or other authority with respect to the securities of the Company separately reported by Mr. Feinberg.

Remarks:
Exhibit List: Exhibit 24 - Power of Attorney

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
INGERSOLL W BRETT C/O TALECRIS BIOTHERAPEUTICS HOLDINGS P.O. BOX 110526 4101 RESEARCH COMMONS RESEARCH TRIANGLE PARK, NC 27709	X

Signatures
/s/ John F. Gaither, Jr., attorney in fact		9/30/2009
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.